Clinical Trial Update: Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage [NA]

View source ↗

Summary

A clinical trial update notes that ticagrelor monotherapy after primary PCI for ST-elevation myocardial infarction is being studied to assess safety and its imp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• ticagrelor (Brilinta) (ticagrelor)

Snippet

Sponsor: Radboud University Medical Center | Conditions: ST Elevation Myocardial Infarction | NA | Status: RECRUITING